tirzepatide cvot Comparison of and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics Tirzepatide Matches Dulaglutide in Large

Future longitudinal studies involving a larger and more diverse global study population are needed to further clarify the long-term corrective effects of triple agonists such as retatrutide, particularly on cardiovascular health outcomes

BMJ Open Diabetes Res Care 2021;9(1)

When appetite signals are absent, external cues replace internal ones

Excess sodium is excreted through urine

In general, peptides composed purely of unmodified natural amino acids do not have optimal drug properties primarily due to their high rate of proteolytic cleavage and consequently short half-life (Di, 2015

Proper use can maximize the medications benefits while reducing the risk of side effects or other problems